Matching slides 303,780
Current window 202,741-202,770
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

202,741-202,770 of 303,780

filter-aware
35
The slide uses a Gantt-style chart to visualize development stages (Concept to Regulatory) for multiple product lines.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
36
The slide uses a color-coded legend to distinguish between testing methodologies (Immunoassay, Molecular, Enzyme, Metabolic/Electrochemical).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
37
The slide emphasizes the breadth of the diagnostic menu available on a single hardware platform.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
38
The chart uses a waterfall-like structure to show market segments, though it is not a true waterfall as the bars do not sum to the total.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
39
The slide uses a horizontal progression to illustrate the shift from centralized lab testing to decentralized home testing.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
40
The slide uses a mix of bulleted lists and visual icons to categorize the technology's deployment across different operational models.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
41
The slide uses a process-like flow to categorize product applications.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
42
The diagram is a circular process flow showing the integration of hardware, software, and pharmacy services.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
43
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
44
The slide highlights current reach and future expansion plans into major diagnostics markets.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
45
The slide uses a matrix structure to segment the market and align products/partners to each segment.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
46
Includes a table of use cases and a bar chart of instrument counts.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
47
Uses a before-and-after framing to demonstrate operational efficiency gains.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
48
Uses a three-column process flow to contrast past problems with current solution and future potential.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
49
The slide displays the LumiraDx point-of-care diagnostic platform alongside a row of various test cartridges.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
50
The chart uses a waterfall structure to represent revenue segmentation across different medical diagnostic categories.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
51
The table tracks cumulative instruments, manufacturing capacity, geographic reach, and revenue breakdowns.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
52
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
53
The slide displays the LumiraDx platform hardware alongside a row of 10 distinct test cartridges (SARS-CoV-2 variants, HbA1c, D-Dimer, INR, NT-proBNP, CRP).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
54
The slide uses a two-column layout to contrast Western healthcare policy shifts with global health development initiatives.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
02
Includes redacted information regarding rollover requirements and specific counterparty details.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
03
Morgan Stanley | Investment Banking Pitch Book | 13 slidesMorgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
04
The table uses checkmarks for completion and various X marks to denote 'No Interest' or 'Re-confirmed no interest' post a specific filing event.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
05
Includes redacted information regarding specific entities and dates.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
06
Includes volume data and specific event markers leading up to the unaffected date of 9/16/2022.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
07
Market data as of 9/27/2022.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
08
Includes specific callouts for 'Unaffected', 'Violet IOI', 'Violet Revised IOI 1', and 'Orange Counter Proposal 1'.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
10
The slide is heavily redacted. It includes a red dashed box highlighting a specific column and a red circle around a cell in that column.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
11
The slide uses a table to compare rollover percentages and amounts across three scenarios for various investors.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
12
Includes a sensitivity table for sponsor equity based on rollover percentage and purchase price, and a pro forma balance sheet adjustment table.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit